The largest real-world comparison of ACURATE neo™ self-expanding valve and SAPIEN 3 balloon expandable valve
1st comparison of ACURATE neo self-expanding valve and SAPIEN 3 balloon expandable valve in patients with small annuli.
An analysis of 249 patients treated using a minimalist approach with ACURATE neo and SAPIEN 3, to assess the success rate and safety of NDD at 90 days and 1 year post procedure.
Analysis of 296 patients with pre-existing complete RBBB comparing ACURATE neo and SAPIEN 3, including a propensity-matched population of 130 patients.
An international, multicenter registry comparing the performance of ACURATE neo and Evolut PRO in 1,551 patients
A single-center trial evaluating the impact of valve selection on procedural outcomes
and length of stay after TAVI in 231 patients. Clinical result after multivariable adjustment, post operative LoS before discharge.